Skip to main content
Log in

Procalcitonin as a marker of severity in septic shock

  • ORIGINAL ARTICLE
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Background/aims: Procalcitonin (PCT) was shown to be related to the severity of bacterial infection and is recommended as a new parameter of inflammation and infection. To evaluate the prognostic value in septic shock, PCT levels were repeatedly determined and compared with tumour necrosis factor-α (TNF-α)- and interleukin (IL)-6 bioactivity as well as with C-reactive protein (CRP) serum levels. Patients: Twenty-four surgical patients with septic shock were included. Eight patients died within the study period of 14 days. Methods: Serum levels of TNF- (WEHI 164) and IL-6 (B13–29 subclone 9) bioactivity, CRP and PCT were determined on days 1, 3, 5, 7, 10 and 14 following diagnosis of septic shock. Results: Survivors and non-survivors were comparable in terms of age and severity of sepsis characterized by the APACHE II score and multiple-organ-failure score. Predominant causes of sepsis were peritonitis and necrotiszing pancreatitis. TNF levels increased in non-survivors with no significant difference to survivors. IL-6 bioactivity was increased on day 1 (P = 0.06) and remained elevated in non-survivors, in whom it was significant on day 7 (P<0.05). CRP was constantly elevated with no difference between the groups. In non-survivors PCT remained increased, while the course of survivors was characterized by decreased values which were significantly lower (P<0.05) at every time point compared with those patients who died. A significant correlation could be found on day 1 (P<0.05) and at the end of the observation period (P<0.01) when comparing PCT levels with the multiple-organ-failure score. Conclusions: PCT seems to be a more reliable prognostic parameter in septic shock than IL-6, while TNF and CRP did not show any difference between survivors and non-survivors. These data indicate that PCT may represent a valuable parameter not only in the diagnosis of sepsis but also in the clinical course of the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 2 December 1997; in revised form: 6 August 1998 Accepted: 17 October 1998

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schröder, J., Staubach, KH., Zabel, P. et al. Procalcitonin as a marker of severity in septic shock. Langenbeck's Arch Surg 384, 33–38 (1999). https://doi.org/10.1007/s004230050170

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004230050170

Navigation